Molecular therapeutics of pancreatic ductal adenocarcinoma:targeted pathways and the role of cancer stem cells
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers in humans due to late detection and highly metastatic characteristics. PDAC cells vary in their tumorigenic capabilities with the presence of a subset of PDAC cells known as pancreatic cancer stem cells (CSCs), which are more...
المؤلفون الرئيسيون: | Stoica, A, Chang, C-H, Pauklin, S |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
Cell Press
2020
|
مواد مشابهة
-
Mechanisms of cancer cell death: Therapeutic implications for pancreatic ductal adenocarcinoma
حسب: Pook, H, وآخرون
منشور في: (2021) -
In-silico identification of therapeutic targets in pancreatic ductal adenocarcinoma using WGCNA and Trader
حسب: Parvin Yavari, وآخرون
منشور في: (2024-10-01) -
TRP Channels Interactome in Pancreatic Ductal Adenocarcinoma: A Potential Therapeutic Target
حسب: Ahmad Taha Khalaf, وآخرون
منشور في: (2023-03-01) -
Therapeutic Status and Available Strategies in Pancreatic Ductal Adenocarcinoma
حسب: Gitika Thakur, وآخرون
منشور في: (2021-02-01) -
Hydrogel-Based Therapeutics for Pancreatic Ductal Adenocarcinoma Treatment
حسب: Jinlu Liu, وآخرون
منشور في: (2023-10-01)